|
Neoplasia
Citations 271-280 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
- Elizabeth C. Bluhm, Cécile Ronckers, Robert J. Hayashi, Joseph P. Neglia, Ann C. Mertens, Marilyn Stovall, Anna T. Meadows, Pauline A. Mitby, John A. Whitton, Sue Hammond, Joseph D. Barker, Sarah S. Donaldson, Leslie L. Robison, and Peter D. Inskip
Blood 2008; 111: 4014-4021.
[Abstract]
[Full text]
[PDF]
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
- Richard A. Larson, Brian J. Druker, Francois Guilhot, Stephen G. O'Brien, Gilles J. Riviere, Tillmann Krahnke, Insa Gathmann, and Yanfeng Wang, for the IRIS (International Randomized Interferon vs STI571) Study Group
Blood 2008; 111: 4022-4028.
[Abstract]
[Full text]
[PDF]
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
- Karin Ekström Smedby, Claire M. Vajdic, Michael Falster, Eric A. Engels, Otoniel Martínez-Maza, Jennifer Turner, Henrik Hjalgrim, Paolo Vineis, Adele Seniori Costantini, Paige M. Bracci, Elizabeth A. Holly, Eleanor Willett, John J. Spinelli, Carlo La Vecchia, Tongzhang Zheng, Nikolaus Becker, Silvia De Sanjosé, Brian C.-H. Chiu, Luigino Dal Maso, Pierluigi Cocco, Marc Maynadié, Lenka Foretova, Anthony Staines, Paul Brennan, Scott Davis, Richard Severson, James R. Cerhan, Elizabeth C. Breen, Brenda Birmann, Andrew E. Grulich, and Wendy Cozen
Blood 2008; 111: 4029-4038.
[Abstract]
[Full text]
[PDF]
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group
- Heinz Ludwig, Brian G. M. Durie, Vanessa Bolejack, Ingemar Turesson, Robert A. Kyle, Joan Blade, Rafael Fonseca, Meletios Dimopoulos, Kazuyuki Shimizu, Jesus San Miguel, Jan Westin, Jean-Luc Harousseau, Meral Beksac, Mario Boccadoro, Antonio Palumbo, Bart Barlogie, Chaim Shustik, Michele Cavo, Philip R. Greipp, Douglas Joshua, Michel Attal, Pieter Sonneveld, and John Crowley
Blood 2008; 111: 4039-4047.
[Abstract]
[Full text]
[PDF]
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
- Naoko Watanabe-Okochi, Jiro Kitaura, Ryoichi Ono, Hironori Harada, Yuka Harada, Yukiko Komeno, Hideaki Nakajima, Tetsuya Nosaka, Toshiya Inaba, and Toshio Kitamura
Blood 2008; 111: 4297-4308.
[Abstract]
[Full text]
[PDF]
Mutation of C/EBP predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen
- Marie S. Hasemann, Inge Damgaard, Mikkel B. Schuster, Kim Theilgaard-Mönch, Annette B. Sørensen, Alan Mrsic, Thijs Krugers, Bauke Ylstra, Finn S. Pedersen, Claus Nerlov, and Bo T. Porse
Blood 2008; 111: 4309-4321.
[Abstract]
[Full text]
[PDF]
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
- Brian V. Balgobind, Pieter Van Vlierberghe, Ans M. W. van den Ouweland, H. Berna Beverloo, Joan N. R. Terlouw-Kromosoeto, Elisabeth R. van Wering, Dirk Reinhardt, Martin Horstmann, Gertjan J. L. Kaspers, Rob Pieters, C. Michel Zwaan, Marry M. Van den Heuvel-Eibrink, and Jules P. P. Meijerink
Blood 2008; 111: 4322-4328.
[Abstract]
[Full text]
[PDF]
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
- Sanne Lugthart, Ellen van Drunen, Yvette van Norden, Antoinette van Hoven, Claudia A. J. Erpelinck, Peter J. M. Valk, H. Berna Beverloo, Bob Löwenberg, and Ruud Delwel
Blood 2008; 111: 4329-4337.
[Abstract]
[Full text]
[PDF]
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
- Farshid Dayyani, Jianfeng Wang, Jing-Ruey J. Yeh, Eun-Young Ahn, Erica Tobey, Dong-Er Zhang, Irwin D. Bernstein, Randall T. Peterson, and David A. Sweetser
Blood 2008; 111: 4338-4347.
[Abstract]
[Full text]
[PDF]
A functional TNFRSF5 gene variant is associated with risk of lymphoma
- Christine F. Skibola, Alexandra Nieters, Paige M. Bracci, John D. Curry, Luz Agana, Danica R. Skibola, Alan Hubbard, Nikolaus Becker, Martyn T. Smith, and Elizabeth A. Holly
Blood 2008; 111: 4348-4354.
[Abstract]
[Full text]
[PDF]
|
|
